(Q53330379)

13 May 2018

title

Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab. (English)

1 reference

13 May 2018

0 references

1 reference

3

1 reference

13 May 2018

Jonathan N. Barker

4

1 reference

13 May 2018

author name string

A-L Chew

1

1 reference

13 May 2018

A Bennett

2

1 reference

13 May 2018

B Kirkham

5

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 August 2004

1 reference

13 May 2018

British Journal of Dermatology

published in

1 reference

13 May 2018

volume

151

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

page(s)

492-496

1 reference

13 May 2018

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06105.X

Infliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06105.X

Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06105.X

Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06105.X

Amyloidosis induced, end stage renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06105.X

Autoimmune thyroid disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06105.X

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06105.X

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06105.X

10.1111/J.1365-2133.2004.06105.X

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018